Estrogen-only systemic MHT

Estrogen-only systemic menopausal hormone therapy (MHT) uses continuous daily estrogen without progestogen and is available in transdermal and oral formulations.

Indications for estrogen-only systemic MHT are listed in Types of systemic menopausal hormone therapy and the appropriate subgroups of menopausal patients. Before starting systemic MHT, individualised assessment of the expected benefits and harms of treatment is needed. For a suggested approach to starting menopausal therapy, including considerations in choosing between oral and transdermal estrogen, see Approach to starting therapy for menopause.

For estrogen-only systemic MHT, use:

estrogen in a low dose, orally or transdermally (see #srg2-c24-s7__tsrg2-c24-tbl3 for dosage and formulations); increase dose if needed (depending on symptoms, age and comorbidities). menopause, estrogen only therapy

See Monitoring systemic MHT and Managing adverse effects of systemic MHT for guidance on adjusting estrogen-only MHT.